While Trump's tariffs could have a broad impact on healthcare prices, it is likely they will not have the devastating result that some may be expecting, health policy and trade experts say.

Fact checked by Nick Blackmer The price of over-the-counter pain medicines, antibiotics, and supplements may spike following ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

This new nonaddictive alternative is the first of its kind that interrupts the pain signal before it reaches the brain.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The U.S. Food and Drug Administration (FDA) has approved a new pain pill called Journavx, designed to mitigate the risks of addiction and overdose associated with opioid medications like Vicodin and ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...

The execs at Haleon, a huge multinational consumer products company, ought to take a good look in the mirror. That is, unless ...